Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Nov;40(11):2598–2604. doi: 10.1128/aac.40.11.2598

Effects of topical erythromycin on ecology of aerobic cutaneous bacterial flora.

B R Vowels 1, D S Feingold 1, C Sloughfy 1, A N Foglia 1, N Konnikov 1, E Ordoukhanian 1, P Starkey 1, J J Leyden 1
PMCID: PMC163583  PMID: 8913472

Abstract

We have demonstrated previously that application of topical erythromycin, an antibiotic commonly used for the treatment of acne, results in an increased density of cutaneous erythromycin-resistant (Emr) coagulase-negative staphylococci; however, it is unknown if this increase results in an overall higher density of total cutaneous staphylococci or if upon cessation of erythromycin use, Emr coagulase-negative staphylococci remain at an increased density compared with the pretreatment density. To investigate this, 2% erythromycin or vehicle was applied to each subject's forehead (n = 225) twice a day by laboratory personnel for a period of 6 weeks. Samples were obtained for culture from the forehead, anterior nares, and back of the subjects at baseline and at weeks 6, 9, and 12 of the study. Cultures were performed on differential media. Plates into which erythromycin was incorporated (8 micrograms/ml) were used to identify Emr coagulase-negative staphylococci. The species of all Emr coagulase-negative staphylococci were determined, and an antibiogram for 16 antibiotics was obtained. The baseline prevalence of Emr coagulase-negative staphylococci on the forehead and nose was about 80% at the two study sites, whereas that on the back was 50%. The baseline density of Emr coagulase-negative staphylococci on the forehead, nose, and back was approximately 20% of the total flora. Following 6 weeks of erythromycin treatment, the prevalence of Emr coagulase-negative staphylococci on the forehead and nose was nearly 100% and the densities were 73 and 62%, respectively; the prevalence and density for the back were 78 and 42%, respectively. The most prevalent erythromycin resistance gene expressed by the Emr coagulase-negative staphylococci was ermC. There was no increase in the numbers of Staphylococcus aureus, gram-negative rods, or yeasts, nor was there increased resistance to any other antibiotic except clindamycin. The density of total aerobic organisms also remained static. There were no changes in the prevalence or density of Emr coagulase-negative staphylococci in the vehicle group. A statistically significant decrease in the prevalence and density of Emr coagulase-negative staphylococci in the erythromycin group was observed within 3 weeks posttreatment and by 6 weeks posttreatment, the prevalence and density returned to baseline values. These data demonstrate that the increased prevalence and density of Emr coagulase-negative staphylococci as a result of topical 2% erythromycin use are transient on both population and individual levels.

Full Text

The Full Text of this article is available as a PDF (240.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arthur M., Brisson-Noël A., Courvalin P. Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypotheses. J Antimicrob Chemother. 1987 Dec;20(6):783–802. doi: 10.1093/jac/20.6.783. [DOI] [PubMed] [Google Scholar]
  2. Cove J. H., Eady E. A., Cunliffe W. J. Skin carriage of antibiotic-resistant coagulase-negative staphylococci in untreated subjects. J Antimicrob Chemother. 1990 Mar;25(3):459–469. doi: 10.1093/jac/25.3.459. [DOI] [PubMed] [Google Scholar]
  3. Eady E. A., Ross J. I., Tipper J. L., Walters C. E., Cove J. H., Noble W. C. Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J Antimicrob Chemother. 1993 Feb;31(2):211–217. doi: 10.1093/jac/31.2.211. [DOI] [PubMed] [Google Scholar]
  4. Fawcett C. J., Lord V. L., Lacey R. W. Failure of coagulase-negative staphylococci to transfer antibiotic resistance to Staphylococcus aureus 1030 in mixed cultures. J Gen Microbiol. 1981 Oct;126(2):507–509. doi: 10.1099/00221287-126-2-507. [DOI] [PubMed] [Google Scholar]
  5. Forbes B. A., Schaberg D. R. Transfer of resistance plasmids from Staphylococcus epidermidis to Staphylococcus aureus: evidence for conjugative exchange of resistance. J Bacteriol. 1983 Feb;153(2):627–634. doi: 10.1128/jb.153.2.627-634.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Harkaway K. S., McGinley K. J., Foglia A. N., Lee W. L., Fried F., Shalita A. R., Leyden J. J. Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy. Br J Dermatol. 1992 Jun;126(6):586–590. doi: 10.1111/j.1365-2133.1992.tb00104.x. [DOI] [PubMed] [Google Scholar]
  7. Hillier L., Green P. OSP: a computer program for choosing PCR and DNA sequencing primers. PCR Methods Appl. 1991 Nov;1(2):124–128. doi: 10.1101/gr.1.2.124. [DOI] [PubMed] [Google Scholar]
  8. Jaffe H. W., Sweeney H. M., Nathan C., Weinstein R. A., Kabins S. A., Cohen S. Identity and interspecific transfer of gentamicin-resistance plasmids in Staphylococcus aureus and Staphylococcus epidermidis. J Infect Dis. 1980 Jun;141(6):738–747. doi: 10.1093/infdis/141.6.738. [DOI] [PubMed] [Google Scholar]
  9. Liss R. H., Batchelor F. R. Economic evaluations of antibiotic use and resistance--a perspective: report of Task Force 6. Rev Infect Dis. 1987 May-Jun;9 (Suppl 3):S297–S312. doi: 10.1093/clinids/9.supplement_3.s297. [DOI] [PubMed] [Google Scholar]
  10. London N., Nijsten R., Mertens P., v d Bogaard A., Stobberingh E. Effect of antibiotic therapy on the antibiotic resistance of faecal Escherichia coli in patients attending general practitioners. J Antimicrob Chemother. 1994 Aug;34(2):239–246. doi: 10.1093/jac/34.2.239. [DOI] [PubMed] [Google Scholar]
  11. McDonnell R. W., Sweeney H. M., Cohen S. Conjugational transfer of gentamicin resistance plasmids intra- and interspecifically in Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother. 1983 Jan;23(1):151–160. doi: 10.1128/aac.23.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McGowan J. E., Jr Abrupt changes in antibiotic resistance. J Hosp Infect. 1991 Jun;18 (Suppl A):202–210. doi: 10.1016/0195-6701(91)90025-4. [DOI] [PubMed] [Google Scholar]
  13. Milatovic D., Braveny I. Development of resistance during antibiotic therapy. Eur J Clin Microbiol. 1987 Jun;6(3):234–244. doi: 10.1007/BF02017607. [DOI] [PubMed] [Google Scholar]
  14. Naidoo J. Interspecific co-transfer of antibiotic resistance plasmids in staphylococci in vivo. J Hyg (Lond) 1984 Aug;93(1):59–66. doi: 10.1017/s0022172400060939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nathwani D., Wood M. J. Penicillins. A current review of their clinical pharmacology and therapeutic use. Drugs. 1993 Jun;45(6):866–894. doi: 10.2165/00003495-199345060-00002. [DOI] [PubMed] [Google Scholar]
  16. Neu H. C. The crisis in antibiotic resistance. Science. 1992 Aug 21;257(5073):1064–1073. doi: 10.1126/science.257.5073.1064. [DOI] [PubMed] [Google Scholar]
  17. Proctor R. A., Wick P., Hamill R. J., Horstmeier P., Gullings-Handley J., Weisensel M., Brandt G. In-vitro studies of antibiotic combinations for multiply-resistant coagulase-negative staphylococci. J Antimicrob Chemother. 1987 Aug;20(2):223–231. doi: 10.1093/jac/20.2.223. [DOI] [PubMed] [Google Scholar]
  18. Righter J. Treatment of coagulase-negative staphylococcal infections: dilemmas for laboratory and clinician. J Antimicrob Chemother. 1987 Oct;20(4):459–462. doi: 10.1093/jac/20.4.459. [DOI] [PubMed] [Google Scholar]
  19. Viljanen P., Boratynski J. The susceptibility of conjugative resistance transfer in gram-negative bacteria to physicochemical and biochemical agents. FEMS Microbiol Rev. 1991 Jul;8(1):43–54. doi: 10.1111/j.1574-6968.1991.tb04956.x. [DOI] [PubMed] [Google Scholar]
  20. Weisblum B. Inducible erythromycin resistance in bacteria. Br Med Bull. 1984 Jan;40(1):47–53. doi: 10.1093/oxfordjournals.bmb.a071947. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES